Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors

NCT01873326 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Germ Cell Tumors

Interventions

DRUG: Paclitaxel
DRUG: Ifosfamide
DRUG: Cisplatin
DRUG: Mesna
DRUG: Bleomycin
DRUG: Etoposide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]